Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
Standard
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial. / Huhn, S; Weinhold, N; Nickel, J; Pritsch, M; Hielscher, T; Hummel, M; Bertsch, U; Huegle-Doerr, B; Vogel, M; Angermund, R; Hänel, M; Salwender, H J; Weisel, K; Dürig, J; Görner, M; Kirchner, H; Peter, N; Graeven, U; Lordick, F; Hoffmann, M; Reimer, P; Blau, I W; Jauch, A; Dembowsky, K; Möhler, T; Wuchter, P; Goldschmidt, H.
in: BONE MARROW TRANSPL, Jahrgang 52, Nr. 8, 08.2017, S. 1194-1198.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
AU - Huhn, S
AU - Weinhold, N
AU - Nickel, J
AU - Pritsch, M
AU - Hielscher, T
AU - Hummel, M
AU - Bertsch, U
AU - Huegle-Doerr, B
AU - Vogel, M
AU - Angermund, R
AU - Hänel, M
AU - Salwender, H J
AU - Weisel, K
AU - Dürig, J
AU - Görner, M
AU - Kirchner, H
AU - Peter, N
AU - Graeven, U
AU - Lordick, F
AU - Hoffmann, M
AU - Reimer, P
AU - Blau, I W
AU - Jauch, A
AU - Dembowsky, K
AU - Möhler, T
AU - Wuchter, P
AU - Goldschmidt, H
PY - 2017/8
Y1 - 2017/8
KW - Adult
KW - Autografts
KW - Biomarkers, Tumor
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Multiple Myeloma
KW - Neoplastic Cells, Circulating
KW - Stem Cell Transplantation
KW - Clinical Trial, Phase III
KW - Journal Article
KW - Multicenter Study
KW - Randomized Controlled Trial
KW - Research Support, Non-U.S. Gov't
U2 - 10.1038/bmt.2017.91
DO - 10.1038/bmt.2017.91
M3 - SCORING: Journal article
C2 - 28504661
VL - 52
SP - 1194
EP - 1198
JO - BONE MARROW TRANSPL
JF - BONE MARROW TRANSPL
SN - 0268-3369
IS - 8
ER -